DAX19.062 +0,3%ESt504.733 +0,1%MSCIW3.739 +0,2%Dow43.574 +0,4%Nas18.877 -0,5%Bitcoin91.670 +2,6%Euro1,0538 ±-0,0%Öl73,93 +1,1%Gold2.665 +0,6%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 MicroStrategy 722713 Bayer BAY001 Tesla A1CX3T Rheinmetall 703000 Porsche PAG911 Volkswagen (VW) vz. 766403 Coinbase A2QP7J Mercedes-Benz Group (ex Daimler) 710000 Palantir A2QA4J Amazon 906866 Siemens Energy ENER6Y Deutsche Telekom 555750 NEL ASA A0B733 EVOTEC 566480
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Anleger unentschlossen: DAX stabil -- Wall Street fällt ins Minus-- NVIDIA übertrifft Erwartungen -- Bitcoin: Neuer Rekord -- Mercedes: Sparkurs -- MicroStrategy, Medios, Rheinmetall im Fokus
Top News
NVIDIA-Aktie von Ausblick belastet: NVIDIA mit kräftigen Zuwächsen bei Gewinn und Umsatz - Starke Prognose nicht stark genug NVIDIA-Aktie von Ausblick belastet: NVIDIA mit kräftigen Zuwächsen bei Gewinn und Umsatz - Starke Prognose nicht stark genug
NASDAQ 100-Handel aktuell: NASDAQ 100 zum Handelsstart leichter NASDAQ 100-Handel aktuell: NASDAQ 100 zum Handelsstart leichter
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Gilead Sciences Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
84,06 EUR -0,41 EUR -0,49 %
XETRA
88,40 USD -0,22 USD -0,25 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.103,79 Mrd. EUR

KGV17,99Div. Rendite3,70%

WKN885823

ISINUS3755581036

SymbolGILD

Gilead Sciences Aktien News

DatumMeistgelesen
ZacksGilead Stock Rises as HIV Prevention Injection Meets Study Goals
MotleyFoolWhy Gilead Sciences Stock Thrashed the Market Today
BenzingaGilead Unveils 'Remarkable Outcomes' From Late-Stage Lenacapavir Study Showing Promise In Preventing HIV Infections
BenzingaWhat the Options Market Tells Us About Gilead Sciences
ZacksGilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know
BenzingaPeering Into Gilead Sciences's Recent Short Interest
BenzingaUnveiling 10 Analyst Insights On Gilead Sciences
BenzingaGilead Sciences Options Trading: A Deep Dive into Market Sentiment
BenzingaDecoding Gilead Sciences's Options Activity: What's the Big Picture?
ZacksGilead (GILD) Gains 16.8% in 3 Months: How Should You Play the Stock?
ZacksInvestors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know
BenzingaPeering Into Gilead Sciences's Recent Short Interest
ZacksGilead (GILD) Obtains FDA Approval for PBC Drug Livdelzi
BenzingaExpert Outlook: Gilead Sciences Through The Eyes Of 8 Analysts
BenzingaAnalysts Cite Improved Investor Sentiment For Gilead, But Warn of Limited Growth at Current Stock Levels
ZacksGilead (GILD) Q2 Earnings Beat, Annual Profit Guidance Raised
MotleyFoolGilead Sciences (GILD) Q2 2024 Earnings Call Transcript
MarketWatchGilead Sciences posts higher Q2 profit and revenue on increased sales
ZacksGilead (GILD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
ZacksGilead Sciences (GILD) Q2 Earnings and Revenues Beat Estimates
Benzinga$1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today
ZacksCountdown to Gilead (GILD) Q2 Earnings: Wall Street Forecasts for Key Metrics
ZacksShould You Buy, Sell or Hold Gilead Sciences (GILD) Before Q2 Earnings?
ZacksIs Eventide Gilead Fund N (ETGLX) a Strong Mutual Fund Pick Right Now?
ZacksGilead Sciences (GILD) Advances While Market Declines: Some Information for Investors
ZacksGilead Sciences (GILD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ZacksHere is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock
BenzingaGilead Sciences's Options Frenzy: What You Need to Know
ZacksGilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know
Benzinga$100 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today
BenzingaThis Is What Whales Are Betting On Gilead Sciences
ZacksGilead Sciences (GILD) Stock Declines While Market Improves: Some Information for Investors
BenzingaBreaking Down Gilead Sciences: 10 Analysts Share Their Views
ZacksGilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
ZacksGilead Sciences (GILD) Beats Stock Market Upswing: What Investors Need to Know
BenzingaGilead Sciences's Options Frenzy: What You Need to Know
ZacksWhy Gilead Sciences (GILD) Outpaced the Stock Market Today
BenzingaLooking Into Gilead Sciences's Recent Short Interest
ZacksGilead (GILD) Loses 17.6% YTD: How Should You Play the Stock?
BenzingaKey Takeaways From Gilead Sciences Analyst Ratings

Gilead Sciences News

Gilead Sciences News: auf dieser Seite finden Sie alle Gilead Sciences News und Nachrichten zur Gilead Sciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Gilead Sciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Gilead Sciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.